Australia
First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial
Highlights * First participant of cohort 3 in the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has been treated at the highest dose level of 12GBq. * Cohort 2 was recently completed in 3 participants who received therapy...
Noodoe Links Californian and Australian Efforts to Combat Global Climate Change
With its newly opened Brisbane offices, Noodoe enables businesses from California to Australia to drive the adoption of sustainable transportation. IRVINE, Calif., Aug. 17, 2023 /PRNewswire/ -- Noodoe today announced the opening of its new offices inBrisbane, Australia as the next step in its wor...
THE CONQUEROR TEAMS UP WITH WARNER BROS. DISCOVERY GLOBAL CONSUMER PRODUCTS TO LAUNCH THE ULTIMATE SERIES OF VIRTUAL FITNESS CHALLENGES INSPIRED BY HBO'S GAME OF THRONES
Five Challenges, Five Medals, Following the Extraordinary Journeys of Jon Snow, Tyrion Lannister,Arya Stark, Daenerys Targaryen, and more. TAURANGA, New Zealand, Aug. 16, 2023 /PRNewswire/ -- The Conqueror Virtual Challenges, in collaboration with Warner Bros. Discovery Global Consumer Products,...
Inmagene's OX40 mAb, with an extended half-life and silenced ADCC, enters POC study in Atopic Dermatitis
SAN DIEGO, SHANGHAI and SYDNEY, Aug. 15, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), a clinical stage biotechnology company developing innovative and differentiated therapies for immunological and inflammatory diseases, announced that the first patient has been dosed in a glob...
HB11 Energy receives grant from US Department of Energy to develop clean, safe and unlimited fusion energy
SYDNEY, Aug. 15, 2023 /PRNewswire/ -- The U.S. Department of Energy (DoE) has
awarded a grant toHB11 Energy
Clarity's theranostic prostate cancer trial advances to highest dose level
Highlights * Cohort 2 of the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has been completed in 3 participants who received therapy with67Cu SAR-bisPSMA at the dose level of 8GBq. * No dose limiting toxicities (DLTs) ha...
AI-based wastewater sampling predicts COVID pressure on hospitals
SYDNEY, Aug. 7, 2023 /PRNewswire/ -- New research shows it is possible to
accurately predict hospital admission numbers due to COVID-19 up to four weeks
in advance with an Artificial Intelligence (AI) based system using COVID
wastewater sampling.
Relume Launches World's First AI-Powered Site Builder that exports to Webflow and Figma
SYDNEY, Aug. 7, 2023 /PRNewswire/ -- Sydney-based startup Relume has launched the world's first AI-powered site builder that exports to Webflow and Figma. The new site builder allows users to easily create website wireframes with just a prompt and export them to Figma and Webflow, saving time and...
Arbele announces early safety data for novel CDH17xCD3 bispecific T-cell engager at American Society of Clinical Oncology Breakthrough Meeting
SYDNEY, Aug. 2, 2023 /PRNewswire/ -- Arbele, a clinical-stage biotechnology company developing novel immunotherapies targeted for advanced gastrointestinal cancers, presented early safety data from its first-in-class CDH17xCD3 bispecific T-cell engager antibody, ARB202, at the ASCO Breakthrough c...
GLOBAL SARCOMA THERAPY NOW LISTED ON PHARMACEUTICAL BENEFITS SCHEME
* YONDELIS® (trabectedin) now PBS listed for Australian patients * Listing described as "wonderful news" for patients living with rare lipo and leiomyo sarcomas * YONDELISÒ (trabectedin) demonstrates 45% reduction in risk of disease progression or death versus dacarbazine1 SINGAPORE, July 31...
Gem Rock Auctions Celebrates Remarkable Milestone of Selling 1 Million Exquisite Gemstones Online
GOLD COAST, Australia, July 30, 2023 /PRNewswire/ -- Gem Rock Auctions, the leading online marketplace for gemstones, celebrates a remarkable milestone as its 320 sellers worldwide have collectively sold over 1 million gemstones to 179 countries. With an impressive inventory of over 1,000 gemston...
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement
* HaemaLogiX and Peter MacCallum Cancer Centre have entered a collaboration agreement to develop and conduct the first Phase I human trial of HaemaLogiX's CAR-T cell therapy in patients with kappa-type myeloma * The agreement is the culmination of previous preclinical research collaboration b...
Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial
SYDNEY, July 24, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity", "the Company"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce the Phas...
New 6clicks Trust Portal Features Combine Transparency and Security for Sharing Compliance and Privacy Information with Customers and Partners
Trust Management System Puts an End to "One Size Fits All" Privacy and
Compliance Statements and Enables Granular Control of Disclosure
MELBOURNE, Australia, July 12, 2023 /PRNewswire/ -- 6clicks
ForwardX Robotics Announces Exclusive Distribution Partnership with Richmond Rolling Solutions
Expanding the Future of Intelligent Automation in Australia and New Zealand BEIJING, July 12, 2023 /PRNewswire/ -- ForwardX Robotics, a global leader in vision-based AMR technology, is thrilled to announce its exclusive distribution partnership with Richmond Rolling Solutions, a renowned provider...
Race executes agreement with Ardena for GMP manufacturing of RC220
* Race Oncology executes agreement with leading global contract development and manufacturing organisation, Ardena as additional partner for GMP manufacturing of flagship RC220 bistanrene formulation * Ardena has a long track record of providing sterile injectable products for all stages of c...
CULTURE TRIP - MILLENNIAL FOCUSED TOUR OPERATOR COMPLETES MBO AND LAUNCHES STRATEGIC REVIEW
LONDON, July 11, 2023 /PRNewswire/ -- Culture Trip
Ankura Strengthens its Cybersecurity and Digital Forensics Capabilities in Asia Pacific
Cyber risk team bolsters service offering to combat clients' increasing exposure to the changing cyber threat landscape SINGAPORE, July 10, 2023 /PRNewswire/ -- Ankura Consulting, LLC ("Ankura"), an independent global expert services and advisory firm, announced it has bolstered its global Cybe...
Western Union: Half of migrants living in Australia say that without being able to send money back home their family would be in poverty
* New research by Western Union finds that without being able to send money back home 51% of migrants living inAustralia believe their family or friends would be in poverty. * The report, which explores the real-world impact of remittance payments, finds that 79% of migrants believe that thei...
Race executes global license agreement with City of Hope to access FTO IP
* Race executes worldwide license agreement with City of Hope, one of the largest cancer research and treatment organisations inthe United States. * Under the agreement, Race will exclusively secure rights to a City of Hope patent application and associated know-how identifying that bisantrene...
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 309 media titles]
2024-04-15 17:33With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 282 media titles]
2024-04-18 21:26Animated Life in Yunnan
[Picked up by 278 media titles]
2024-04-18 14:00China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 277 media titles]
2024-04-19 13:25